In this episode, experts at Boyds, Chris Moore and Shalini Gupta break down the UK Clinical Trial Regulation (UK CTR), exploring why the reform was introduced and highlighting the practical changes sponsors need to know - including new terminology, updated timelines, notifiable trials, transparency obligations, safety reporting, and labelling updates.
Listeners will gain insight into how these changes will affect trial set-up and operations, what to prepare for ahead of the 28 April 2026 implementation date, and where opportunities exist for faster, more predictable approvals.
Fler avsnitt av Conversations in Drug Development
Visa alla avsnitt av Conversations in Drug DevelopmentConversations in Drug Development med Boyds finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
